MAPT and Alzheimer disease: One of the earliest observed neuronal signaling alterations that directly associates with AD features and risk factors, such as amyloid and tau pathology, synaptic deficits, oxidative stress, and cell death, is intracellular Ca2+ dysregulation [2, 13–15].